Timothy Hoey Insider Profile

Timothy Hoey, SVP, Cancer Biology at OncoMed Pharma, holds 47.18K shares in OncoMed Pharma (Ticker: OMED).
Timothy Hoey

Timothy Hoey
OncoMed Pharma (OMED)
SVP, Cancer Biology

Not Ranked
Timothy Hoey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Timothy Hoey does not currently own shares as a corporate insider.
A breakdown of Timothy Hoey's holdings

Insider Roles

Timothy Hoey does not currently hold a role as a corporate insider.
Roles that Timothy Hoey holds in companies

Most Profitable Insider Trade

OncoMed Pharma
Rating:Informative Sell
Date:Jan 08, 2016 - Jan 08, 2017
The most profitable trade made by Timothy Hoey

Timothy Hoey's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OncoMed Pharma
Apr 25, 2017
Uninformative Buy
OMED is no longer traded
Success Rate for OMED
1 out of 1 profitable transactions on OMED
Average Return for OMED
Average return per transaction on OMED
No. of Shares
Price per Share
Link to Report
Mar 27, 2014
Uninformative Buy
Jul 17, 2013
Uninformative Buy
Jul 23, 2013
Uninformative Buy
Mar 07, 2014
Uninformative Sell
Feb 07, 2014
Uninformative Sell
List of latest transactions for each holding click on a transaction to see Timothy Hoey's performance on stock

Timothy Hoey insider profile FAQ

What is the percentage of profitable transactions made by Timothy Hoey?
The percentage of profitable transactions made by Timothy Hoey is ―.
    What is the average return per transaction made by Timothy Hoey?
    The average return per transaction made by Timothy Hoey is ―.
      What stocks does Timothy Hoey hold?
      Timothy Hoey holds: OMED stocks.
        What was Timothy Hoey’s latest transaction?
        Timothy Hoey latest transaction was an Uninformative Buy of ―.
          What was Timothy Hoey's most profitable transaction?
          Timothy Hoey’s most profitable transaction was an Informative Sell of OMED stock on January 8, 2016. The return on the trade was 57.80%.
            What is Timothy Hoey's role in OncoMed Pharma?
            Timothy Hoey's role in OncoMed Pharma is SVP, Cancer Biology.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.